Discover how BioEP can help:
BioEP - a novel digital biomarker of epilepsy
BioEP is a tool that provides objective decision support to healthcare professionals to help inform the likelihood of seizures, enabling faster and more accurate diagnosis and prognosis of epilepsy.
Neuronostics was spun out of the University of Exeter in 2018. Our team are dedicated to developing novel biomarkers to help improve the lives of people living with neurological conditions. We are a diverse group with expertise in clinical, scientific, technology, operations and innovation fields. Supported by Innovate UK, NIHR and private equity, we won the Medilink UK National Start Up of the Year Award in 2020 and are currently focussed on trialling our technology in clinic.